Bayer is an innovation company with a more than 150-year history and core competencies in the fields of health care and agriculture. We develop new molecules for use in innovative products and solutions to improve the health of humans, animals and plants. Our research and development activities are based on a profound understanding of the biochemical processes in living organisms.
Following the economic and legal separation of our MaterialScience business, now Covestro*, Bayer has charted the course for its successful development as a Life Science company. In this connection, we have realigned our corporate structure. Since January 1, 2016, Bayer’s core business has been managed by three divisions: Pharmaceuticals, Consumer Health and Crop Science. Animal Health is a separate reporting segment.
Our Life Science businesses hold leading positions in innovation-driven growth markets. Together they make up a strong, attractive and balanced portfolio that is resistant to fluctuations in demand and to potential risks. The previous structure comprising a strategic management holding company and operational subgroups has thus been replaced by an integrated organization under the umbrella of the strong Bayer brand.
On September 30, 2015, the Bayer Group had 102,168 employees worldwide.